EUVIMEDEUVIMED entdecken
Fallbericht

Dramatic Improvement of Iatrogenic Subcutaneous Atrophy After Steroid Temporomandibular Joint (TMJ) Injections: A Case Report

Chester Tyson, Dean Morrell

Journal of Dermatology Research · 2026

DOI: 10.46889/jdr.2026.7104 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Dermatology Research, 2026. Verfasst von Chester Tyson und 1 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Intra-articular steroid injections are a common treatment of Temporomandibular Joint (TMJ) involvement in Juvenile Idiopathic Arthritis (JIA), effectively reducing inflammation and symptoms. However, regional subcutaneous atrophy is a possible complication following these injections. This can produce facial deformities and long-term cosmetic as well as functional consequences. Case Presentation: We present the case of a pediatric patient with JIA including TMJ involvement who developed significant regional subcutaneous atrophy following bilateral TMJ intra-articular steroid injections. Her JIA was initially treated with methotrexate and then switched to abatacept for improved disease control. Notably, within months of the abatacept initiation, there was complete resolution of prior affected areas with no residual cutaneous or subcutaneous atrophy. Because corticosteroid injection induced cutaneous atrophy can be permanent, this case suggests the possible role of abatacept for the treatment of steroid- induced soft tissue atrophy in the setting of systemic treatment of JIA.

Conclusion

This case is the first to document abatacept’s potential involvement in significant and rapid efficacy in resolving iatrogenic-induced subcutaneous atrophy following TMJ intra- articular steroid injections. Abatacept’s mechanism of action of targeting T-cell activation and reducing inflammation may extend beyond arthritis treatment and into tissue repair. Further research is needed to explore abatacept’s role in reversing steroid-induced atrophy and optimizing treatment strategies for pediatric patients experiencing this complication.

Zitieren

APA

Tyson, C., & Morrell, D. (2026). Dramatic Improvement of Iatrogenic Subcutaneous Atrophy After Steroid Temporomandibular Joint (TMJ) Injections: A Case Report. Journal of Dermatology Research. https://doi.org/10.46889/jdr.2026.7104

Vancouver

Tyson C, Morrell D. Dramatic Improvement of Iatrogenic Subcutaneous Atrophy After Steroid Temporomandibular Joint (TMJ) Injections: A Case Report. Journal of Dermatology Research. 2026. doi:10.46889/jdr.2026.7104

BibTeX
@article{Tyson2026,
  author = {Tyson, Chester and Morrell, Dean},
  title = {Dramatic Improvement of Iatrogenic Subcutaneous Atrophy After Steroid Temporomandibular Joint (TMJ) Injections: A Case Report},
  journal = {Journal of Dermatology Research},
  year = {2026},
  doi = {10.46889/jdr.2026.7104}
}
Kostenlos starten →